R J Rees. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clofazimine/therapeutic useCosts and Cost AnalysisDapsone/therapeutic useDrug Resistance, MicrobialHumansLeprostatic Agents/therapeutic useLeprosy/drug therapyLeprosy/prevention & controlProthionamide/therapeutic useRifampin/therapeutic use
Substances: See more » Leprostatic AgentsProthionamideDapsoneClofazimineRifampin
Year: 1983 PMID: 6888143 DOI: 10.5935/0305-7518.19830012
Source DB: PubMed Journal: Lepr Rev ISSN: 0305-7518 Impact factor: 0.537